cometadata/datacite-rtg-text-other-reclassification-records huggingface dataset:
E03485: Gregory of Tours, in his Miracles of Martin (3.2), recounts how a twelve-year-old girl who was disabled, blind and deaf was cured at the tomb of *Martin (ascetic and bishop of Tours, ob. AD 397, S00050) in Tours during his festival; AD 581. Written in Latin in Tours (north-west Gaul), 581/588.
Creators: name: Kwojtalik
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Gregory of Tours, Miracles of Martin (Libri de virtutibus sancti Martini episcopi) 3.2

Summary:

The parents of a disabled, blind and deaf girl who was twelve-years-old prayed at the tomb of Martin. Then on the third day of the festival of Martin the girl called her father and said that she was thirsty. After she asked, her father took her right hand and the girl stood on her own feet. She was healed and recovered her vision and her hearing.

Text: Krusch 1969, 182-183. Summary: Katarzyna Wojtalik.
Supplemental Material, sj-pdf-1-orm-10.1177_1094428120986851 - Sample Selection in Systematic Literature Reviews of Management Research
Creators: name: Hiebl, Martin R. W.
Publisher: name: SAGE Journals
Year: 2021
Subjects: Organisation and Management Theory
Sociological Methodology and Research Methods

description: Supplemental Material, sj-pdf-1-orm-10.1177_1094428120986851 for Sample Selection in Systematic Literature Reviews of Management Research by Martin R. W. Hiebl in Organizational Research Methods
Additional file 1 of Changes of serum IgG glycosylation patterns in rheumatoid arthritis
Creators: name: Deng, Xiaoyue
name: Liu, Xiaomin
name: Zhang, Yan
name: Ke, Dan
name: Yan, Rui
name: Wang, Qian
name: Tian, Xinping
name: Li, Mengtao
name: Zeng, Xiaofeng
name: Hu, Chaojun
Publisher: name: figshare
Year: 2024
Subjects: subject: Biochemistry
subject: Cell Biology
subject: Genetics
subject: FOS: Biological sciences
subject: Biotechnology
subject: Chemical Sciences not elsewhere classified
subject: Ecology
subject: Immunology
subject: FOS: Clinical medicine
subject: Biological Sciences not elsewhere classified
subject: Developmental Biology
subject: Cancer

description: Additional file 1. Diagram of lectin microarray and heat map of lectin results: Fig. S1. Lectin microarray technology containing 56 lectins to depict the glycosylation profile of RA. The red fluorescence indicates the binding signal of serum IgG and lectin. Fig. S2. Heat map of 56 lectin results from microarray analysis. Rows: HC, DC, RA, and RA subgroups; columns: lectins. Preferred binding sugars for lectins were listed for each lectin. Color key indicates standardized fluorescent intensity for lectins, blue: lowest; red: highest. The heatmap was generated using the heatmap package (version 1.0.8) of the R software (version 3.2.2).
E03486: Floor-mosaics with fragmentary Greek epigrams commemorating the construction or embellishment of a church, probably dedicated to *Maurikios (soldier and martyr of Apamea, S01437) by a bishop. Found at Apamea on the Orontes (Roman province of Syria II). Datable c. 415-431.
Creators: name: Pnowakowski
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Janine Balty discusses a structure excavated c. 300 m to the north of the city walls of Apamea. Based on the floor-mosaics found at the site and the Martyrdom of Maurikios of Apamea and his 70 companions, she identifies the building as a martyr shrine dedicated to that saint.

Balty mentions two fragmentary mosaic inscriptions (unpublished), probably with poems (elegiac couplets), sited on the east border of the carpet mosaic of the nave, on both sides of the steps leading to the choir. The first contains an invocation of one Maurikios, probably a saint:

Μαυρίκιε, σέ [- - -]

'O Maurikios, you [- - -]'

The other mentions a bishop:

[Ἀλέξα]νδρος ὑποφήτης

'[Alexa]ndros, the preacher'

and

[- - -]ίης ἔργον ἐπισκοπίης

'[- - -] work of the episcopal stewardship'.

Text: Balty 2013. Translation: P. Nowakowski.
sj-pdf-1-ajr-10.1177_1945892421992659 - Supplemental material for Educational Informed Consent Video Equivalent to Standard Verbal Consent for Rhinologic Surgery: A Randomized Controlled Trial
Creators: name: Penn, Joseph P.
name: Rohit Nallani
name: Dimon, Erin L.
name: Daniels, Taylor C.
name: Sykes, Kevin J.
name: Chiu, Alexander G.
name: Villwock, Mark R.
name: Villwock, Jennifer A.
Publisher: name: SAGE Journals
Year: 2021
Subjects: subject: 110315 Otorhinolaryngology
subject: FOS: Clinical medicine

description: Supplemental material, sj-pdf-1-ajr-10.1177_1945892421992659 for Educational Informed Consent Video Equivalent to Standard Verbal Consent for Rhinologic Surgery: A Randomized Controlled Trial by Joseph P. Penn BS, Rohit Nallani MD, Erin L. Dimon BS, Taylor C. Daniels BS, Kevin J. Sykes PhD, MPH, Alexander G. Chiu MD, Mark R. Villwock MS, Jennifer A. Villwock MD in American Journal of Rhinology & Allergy
Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study
Creators: name: Xing, Lu
name: Long, Lingsheng
name: Wu, Tao
name: Yin, Lingrui
name: Yu, Li
name: Wu, Jingnan
name: Li, Danchen
name: Miao, Limin
name: Shu, Hong
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Space Science
subject: Medicine
subject: Pharmacology
subject: Biotechnology
subject: Immunology
subject: FOS: Clinical medicine
subject: Developmental Biology
subject: Science Policy
subject: Mental Health
subject: Infectious Diseases
subject: FOS: Health sciences

description: Purpose: To evaluate the long-term efficacy and safety of secukinumab in pediatric patients with generalized pustular psoriasis (GPP). Materials and methods: A retrospective study was conducted from July 2021 to July 2024, including 10 children with GPP. Patients were divided into two age groups: children aged 0–3 years received 75 mg of secukinumab, while those aged 3–12 years received 150 mg. Secukinumab was administered subcutaneously at weeks 0, 1, 2, 3, and 4, followed by maintenance every 4 weeks. Treatment response was evaluated using the Generalized Pustular Psoriasis Area and Severity Index (GPPASI), Japanese Dermatological Association (JDA) score, and Infants’/Children’s Dermatology Life Quality Index (IDLQI/CDLQI). Results: By week 1, all patients achieved GPPASI-50 and mild JDA scores. By week 2, eight patients reached GPPASI-100, and nine achieved JDA scores of 0/1. Between weeks 12 and 70, all patients maintained GPPASI-100 and JDA scores of 0. Minimal relapses occurred in four patients, and one experienced five flares. The mean IDLQI/CDLQI improved from 21.8 at baseline to 0.4 by week 4, with sustained improvements throughout. Conclusions: Secukinumab demonstrated long-term efficacy and safety in pediatric GPP, significantly improving clinical outcomes and quality of life, with no serious adverse events reported.
sj-docx-1-cad-10.1177_0011128721989072 – Supplemental material for Parental Migration and Risk of Sexual Assault Against Children in Rural China
Creators: name: Xiaojin Chen
name: Yuning Wu
name: Qu, Jia
Publisher: name: SAGE Journals
Year: 2021
Subjects: subject: 160299 Criminology not elsewhere classified
subject: FOS: Law

description: Supplemental material, sj-docx-1-cad-10.1177_0011128721989072 for Parental Migration and Risk of Sexual Assault Against Children in Rural China by Xiaojin Chen, Yuning Wu and Jia Qu in Crime & Delinquency
Epidemiology, genetics and management of vitiligo in the USA: an All of Us investigation
Creators: name: Gupta, Aditya K.
name: Economopoulos, Vasiliki
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Medicine
subject: Genetics
subject: FOS: Biological sciences
subject: Biotechnology
subject: Environmental Sciences not elsewhere classified
subject: Ecology
subject: Biological Sciences not elsewhere classified
subject: Science Policy

description: Vitiligo is an autoimmune skin depigmentation disorder significantly impacting quality of life. This condition is difficult to treat, with high relapse rates. Additionally, vitiligo associates with other autoimmune conditions, complicating patient management. Improving patient outcomes relies on understanding vitiligo’s clinical landscape and genetic risk factors. We aimed to understand vitiligo’s patient distribution, current management practices, how comorbid autoimmune conditions influence treatment and how genetic risk factors vary in diverse populations. We conducted a cross-sectional study of the All of Us research program, consisting of surveys, electronic health records and genomic data from 206,173 participants in the USA recruited between the summer of 2017 and 1 July 2022. We determined diagnostic and prescribing rates and elucidated differences in genetic risk within different populations. Oral corticosteroids are most frequently prescribed, followed by other immunosuppressive drugs and topical medications. Comorbid systemic lupus erythematosus impacted treatment choices. Single nucleotide polymorphisms associated with increased risk in patients of European decent were not always associated with increase risk in patients of other ancestry. This work highlights the current treatment landscape for vitiligo in the USA. We demonstrated that comorbid conditions impact treatment choices and genetic risk factors vary between ethnic groups. This study highlights differences in vitiligo management where comorbid conditions, such as systemic lupus erythematosus, may influence treatment decisions. We also demonstrate the diversity in genetic risk factors, where some single nucleotide polymorphisms that are a risk in one ethnic group are not a risk in another.
E03487: Gregory of Tours, in his Miracles of Martin (3.3), recounts how a man, who ground grain on a Sunday, had his hand stuck to the lever of the mill; he went to the church of *Martin (ascetic and bishop of Tours, ob. 397, S00050) in Tours, where his hand was released. Another year he did the same, and, after two years, was again released during Martin's festival; AD 581. Written in Latin in Tours (north-west Gaul), 581/588.
Creators: name: Kwojtalik
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Gregory of Tours, Miracles of Martin (Libri de virtutibus sancti Martini episcopi) 3.3

Summary:

A man who did not respect Sunday and turned a millstone was unable to open his hand, and against his will held onto the lever (fustis) that he had picked up. After he went to the church of Martin, prayed there and celebrated vigils, his hand was relaxed. Another year he performed the same task on Sunday and again was punished. He went to Martin’s church and was not immediately released; but two years later his hand was freed at the time of Martin's feast.

Text: Krusch 1969, 183. Summary: Katarzyna Wojtalik.
Additional file 1 of Identification of RimR2 as a positive pathway-specific regulator of rimocidin biosynthesis in Streptomyces rimosus M527
Creators: name: Li, Huijie
name: Hu, Yefeng
name: Zhang, Yongyong
name: Ma, Zheng
name: Bechthold, Andreas
name: Yu, Xiaoping
Publisher: name: figshare
Year: 2024
Subjects: subject: Genetics
subject: FOS: Biological sciences

description: Additional file 1: Table S1. Detailed information of RimR2 and some polyene macrolide biosynthesis regulators from other Streptomyces species in phylogenetic tree.
E03488: Gregory of Tours, in his Miracles of Martin (3.4), recounts how a man from Limoges (western Gaul) who was blind and did not have the use of his limbs was cured at the tomb of *Martin (ascetic and bishop of Tours, ob. AD 397, S00050) in Tours; AD 581. Written in Latin in Tours (north-west Gaul), 581/588.
Creators: name: Kwojtalik
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Gregory of Tours, Miracles of Martin (Libri de virtutibus sancti Martini episcopi) 3.4

Summary:

A man with disabled limbs (contractus), who was also blind, from Limoges was carried to the tomb of Martin. After this man had prayed, he was restored to health.

Text: Krusch 1969, 183. Summary: Katarzyna Wojtalik.
Additional file 4 of Diagnostic potential of myocardial early systolic lengthening for patients with suspected non-ST-segment elevation acute coronary syndrome
Creators: name: Zhang, Wanwei
name: Cai, Qizhe
name: Lin, Mingming
name: Tian, Runyu
name: Jin, Shan
name: Qin, Yunyun
name: Lu, Xiuzhang
Publisher: name: figshare
Year: 2024
Subjects: subject: Medicine
subject: Cell Biology
subject: Genetics
subject: FOS: Biological sciences
subject: Developmental Biology
subject: Virology

description: Additional file 4. Supplemental Table 3. ROC curve results to predict significant coronary branch stenosis.
Supplemental Material, Supplementary_-_After-hours_-_v4.2_-_clean_(2) - After-Hours/Nighttime Transfers Out of the Intensive Care Unit and Patient Outcomes: A Systematic Review and Meta-Analysis
Creators: name: Moshynskyy, Anton I.
name: Mailman, Jonathan F.
name: Sy, Eric J.
Publisher: name: SAGE Journals
Year: 2020
Subjects: subject: 110305 Emergency Medicine
subject: FOS: Clinical medicine
subject: 111702 Aged Health Care
subject: FOS: Health sciences
subject: 110203 Respiratory Diseases

description: Supplemental Material, Supplementary_-_After-hours_-_v4.2_-_clean_(2) for After-Hours/Nighttime Transfers Out of the Intensive Care Unit and Patient Outcomes: A Systematic Review and Meta-Analysis by Anton I. Moshynskyy, Jonathan F. Mailman and Eric J. Sy in Journal of Intensive Care Medicine
The efficacy of narrowband ultraviolet B phototherapy combination with tofacitinib in the treatment of vitiligo: a randomized controlled trial
Creators: name: Guo, Xiaoyan
name: Zhang, Dongxu
name: Chen, Guangxiong
name: Xie, Yijie
name: Mao, Yibin
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Medicine
subject: Cell Biology
subject: Biotechnology
subject: Chemical Sciences not elsewhere classified
subject: Ecology
subject: FOS: Biological sciences
subject: Immunology
subject: FOS: Clinical medicine
subject: Developmental Biology
subject: Cancer
subject: Science Policy

description: This randomized control clinical trial aimed to evaluate the efficacy of tofacitinib combined with phototherapy narrowband ultraviolet B (UVB) in the treatment of vitiligo. A total of 136 vitiligo patients were randomized to UVB treatment (UVB group) or UVB treatment combined with tofacitinib (TOF-UVB group). The patients were followed up for 24 weeks. In post-treatment analysis of treatment outcomes, the vitiligo area severity index (VASI) and dermatology life quality index (DLQI) were measured. Serum levels of inflammatory factors including IL-17, IL-23, IFN-γ and IL-6, were measured with enzyme-linked immunosorbent assay. In post-treatment analysis, significantly more patients in the TOF-UVB group (n = 63) showed effective recovery compared to the UVB group (n = 61). TOF-UVB group also demonstrated markedly lower VASI and DLQI scores than the UVB group. Pronouncedly lower levels of inflammatory factors were also observed. Our data suggest that UVB-TOF is potentially more effective than UVB alone in promoting recovery of vitiligo patients and reducing inflammatory factors.
MPEC 2025-F47 : 2025 FA1
Creators: name: Minor Planet Center Staff
Publisher: name: The Minor Planet Center
Year: 2025
Subjects: subject: Small Solar System bodies
valueUri: http://astrothesaurus.org/uat/1469
subject: 2025 FA1

description: The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements.  They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
title: Klimaschutzmaßnahmen im LULUCF-Sektor: Potenziale und Sensitivitäten
Creators: name: (:Unkn) Unknown
Publisher: name: Umweltbundesamt
Year: 2024
Subjects: subject: THG-Neutralität
subject: Bundes-Klimaschutzgesetz
subject: LULUCF
subject: Senken
subject: Forstwirtschaft
subject: Klima | Energie

description: Um das Ziel der Treibhausgasneutralität bis 2045 gemäß des Bundes-Klimaschutzgesetzes in Deutschland erreichen zu können, müssen, die nach aktuellem Stand der Forschung nicht zu vermeidenden Emissionen, z.B. aus der Landwirtschaft, durch natürliche Kohlenstoffsenken aufgenommen werden. Der Forschungsbericht widmet sich potenziellen Beiträgen der natürlichen Kohlenstoffsenken und landbasierten Emissionsquellen im Sektor ⁠LULUCF⁠ - ⁠Landnutzung⁠, Landnutzungsänderungen und Forstwirtschaft, engl. land use, land use change and forestry.Im Einzelnen werden die notwendigen Maßnahmen und entsprechenden Wirkungszeiträume wichtiger Senken- und Emissionsminderungspotenziale dargestellt. Darüber hinuas werden die Sensitivitäten dieser Potenziale aufgezeigt, wenn z.B. zukünftig mit vermehrten Störungen, wie Dürreperioden zu rechnen ist.Der Bericht ist Teil des vom Umweltbundesamt in Auftrag gegebenen Vorhabens „Transformation zu einem vollständig treibhausgasneutralen Deutschland“, kurz „CARE“.
E03489: Gregory of Tours, in his Miracles of Martin (3.5), recounts how a bind man had his sight restored at the feast of *Martin (ascetic and bishop of Tours, ob. 397, S00050) in Tours; AD 581. Written in Latin in Tours (north-west Gaul), 581/588.
Creators: name: Kwojtalik
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Gregory of Tours, Miracles of Martin (Libri de virtutibus sancti Martini episcopi) 3.5

Summary:

A blind man who prayed at the tomb of Martin at the time of his festival was healed.

Text: Krusch 1969, 183. Summary: Katarzyna Wojtalik.
Additional file 2 of Oral challenge vs routine care to assess low-risk penicillin allergy in critically ill hospital patients (ORACLE): a pilot randomised controlled trial
Creators: name: Rose, Morgan
name: Holmes, Natasha
name: Eastwood, Glenn
name: Vogrin, Sara
name: James, Fiona
name: Phung, Michelle
name: Barnes, Sara
name: Murfin, Brendan
name: Rogers, Ben
name: Lambros, Belinda
name: Peel, Trisha
name: Gibney, Grace
name: Slavin, Monica
name: Trubiano, Jason
Publisher: name: figshare
Year: 2024
Subjects: subject: Medicine
subject: Cell Biology
subject: Pharmacology
subject: Biotechnology
subject: Immunology
subject: FOS: Clinical medicine
subject: Cancer
subject: Infectious Diseases
subject: FOS: Health sciences
subject: Virology
subject: Computational Biology

description: Additional file 2. PEN-FAST.
E03490: Gregory of Tours, in his Miracles of Martin (3.6), recounts how a disabled boy from Tours was brought by his parents to the church of *Martin (ascetic and bishop of Tours, ob. 397, S00050) in Tours and was cured there after three days; AD 581/582. Written in Latin in Tours (north-west Gaul), 581/588.
Creators: name: Kwojtalik
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Gregory of Tours, Miracles of Martin (Libri de virtutibus sancti Martini episcopi) 3.6

Summary:

A disabled boy of Tours was carried by his parents to the church of Martin. The boy and his parents prayed and fasted and on the third day the boy was cured.

Text: Krusch 1969, 183. Summary: Katarzyna Wojtalik.
E03491: Gregory of Tours, in his Miracles of Martin (3.7), recounts how Senator, a man from Craon (north-west Gaul), who could not open his hand, was cured after he prayed to *Martin (ascetic and bishop of Tours, ob. 397, S00050); AD 581/582. Written in Latin in Tours (north-west Gaul), 581/588.
Creators: name: Kwojtalik
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Gregory of Tours, Miracles of Martin (Libri de virtutibus sancti Martini episcopi) 3.7

Summary:

Senator, a man from Craon in the territory of Angers, made a key on a Sunday and the fingers of both his hands stiffened and his fingernails pierced his palms. After four months, he came to Martin's tomb, and prayed and fasted for four days. Then his hands were healed.

Text: Krusch 1969, 183-184. Summary: Katarzyna Wojtalik.
Systematic review, methodological appraisal, and recommendation mapping of clinical practice guidelines for managing patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
Creators: name: AlFada, Mohammed
name: Alotaibi, Hend
name: Alsharif, Sahar
name: Alani, Ahmad Hecham
name: Andrade-Miranda, Andrea
name: Guevara, Camila Montesinos
name: Chen, Yaolong
name: Lei, Ruobing
name: Acosta-Reyes, Jorge
name: Velásquez-Salazar, Pamela
name: El-Malky, Ahmed
name: Amer, Yasser S.
Publisher: name: Taylor & Francis
Year: 2025
Subjects: Medicine
Cancer
Science Policy

description: The Appraisal of Guidelines for Research and Evaluation II Instrument (AGREE II) was developed to enhance the methodological rigor of clinical practice guidelines (CPGs), aiming to generate trustworthy recommendations for various clinical scenarios. Despite its importance, there exists a gap in the quality of CPGs pertaining to Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis (SJS-TEN). The aim of the study was to evaluate SJS-TEN CPGs to shed light on areas for enhancing SJS-TEN guidelines’ quality. A systematic review was conducted to identify SJS-TEN CPGs from January 2011 to December 2023 across bibliographic and guideline databases, as well as dermatology association websites. Four reviewers employed the AGREE II instrument to appraise the quality of eligible CPGs. Subsequently, AGREE II domain scores were calculated and their recommendations mapped. Seven eligible SJS-TEN CPGs reviewed, originating from Europe, North America, Asia, and an authorship Group. The highest AGREE II domain scores were observed in scope and purpose (mean: 63%, standard deviation [SD]: 23.195%) and clarity of presentation (mean: 70%, SD: 14.5%). Conversely, the lowest score was noted in the applicability domain (mean: 28%, SD: 17.44%). Only two guidelines by the British Association of Dermatologists (28.6%) met the ‘recommend’ level. Recommendations from all CPGs were compared in tabular form.
title: Pyrethroide in Arzneimitteln, Bioziden und Pflanzenschutzmitteln - häufig genutzt, selten im Fokus
Creators: name: Hitzfeld, Kristina
name: Weisner, Oliver
name: Meier, Christiane
name: Hein, Arne
Publisher: name: My University
Year: 2024
Subjects: subject: Pyrethroide
subject: Arzneimittel
subject: Biozide
subject: Pflanzenschutzmittel
subject: 500 Naturwissenschaften und Mathematik::540 Chemie
subject: Chemikalien

description: Pyrethroide sind eine Gruppe hochtoxischer Pestizide, die nicht nur als Insektizid in der Landwirtschaft, sondern auch zur Schädlingsbekämpfung im Haushalt oder als Arzneimittel gegen Parasiten eingesetzt werden. Aufgrund ihrer chemischen Eigenschaften sind Pyrethroide in Umweltmedien jedoch nur mit großem technischem Aufwand nachweisbar. So kommt es, dass ihre analytischen Bestimmungsgrenzen in vielen Monitoringkampagnen über den relevanten Grenzwerten liegen und Risiken für die Umwelt nicht erkannt werden können.Das Umweltbundesamt ist zuständig für die Umweltrisikobewertung von Wirkstoffen und Produkten, die in Deutschland als Pestizide und Arzneimittel verfügbar sind. Pyrethroide fallen bei der Bewertung in den Zulassungsverfahren auf, weil sie schon in kleinsten Mengen hochgiftig für Insekten sind und so zum Beispiel die Ökosysteme an Land und in Gewässern schädigen können. Gleichzeitig werden durch Verbote anderer Wirkstoffe immer mehr pyrethroidhaltige Mittel eingesetzt, ohne dass deren Eintrag und Verteilung in der Umwelt in Deutschland routinemäßig untersucht wird. Messungen aus der Schweiz und den Niederlanden weisen jedoch darauf hin, dass Pyrethroide eine enorme Belastung für Bäche und Flüsse darstellen. Aus Sicht des Umweltbundesamtes ist es daher dringend erforderlich Pyrethroide in den Fokus der Umweltüberwachung zu rücken, um das Ausmaß ihres Vorkommens in der Umwelt und ihren Beitrag zur Biodiversitätskrise zu klären. Bislang fehlt eine belastbare und repräsentative Datenbasis, auf deren Grundlage Maßnahmen zur Verringerung des Eintrags abgeleitet und bewertet werden können. Dieser Vortrag wird einen Überblick über die Umweltrisikobewertung von Pyrethroiden, mögliche Eintragspfade in, sowie Risiken für die Umwelt geben. Die Herausforderungen, die diese Stoffgruppe mit sich bringt, werden aufgezeigt und aktuelle Projekte vorgestellt. Insbesondere neuere Aktivitäten zum Umweltmonitoring und die dabei erhaltenen Daten deuten darauf hin, dass Pyrethroide in Zulassung, Anwendung, Forschung und Monitoring deutlich mehr Aufmerksamkeit bekommen sollten. Quelle: Autorinnen*Autoren
E03493: Gregory of Tours, in his Miracles of Martin (3.9), recounts how a cleric from Poitiers (western Gaul) who was lame in one foot visited the church of *Martin (ascetic and bishop of Tours, ob. AD 397, S00050) in Tours, and was cured there three days before the saint's feast in November 582. Written in Latin in Tours (north-west Gaul), 582/588.
Creators: name: Kwojtalik
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Gregory of Tours, Miracles of Martin (Libri de virtutibus sancti Martini episcopi) 3.9

Summary:

A cleric from Poitiers, who had lost the use of one foot, through, he believed, an assault by a midday demon (per incursum daemonii meridiani), nine years later went to the church of Martin, and after after praying for three days his knee was straightened. This happened three days before the feast of Martin.

Text: Krusch 1969,184-185. Summary: Katarzyna Wojtalik.
Additional file 2 of Risk factors for perioperative blood transfusion in patients undergoing total laparoscopic hysterectomy
Creators: name: Cao, Xianghua
name: Liu, Xueliang
name: Zhang, Xingxing
name: Zhang, Kefang
name: Chen, Chuan
name: Yang, Qinfeng
name: Wang, Jian
name: Li, Xueping
name: Wei, Ling
Publisher: name: figshare
Year: 2024
Subjects: Medicine
Pharmacology
Biotechnology
Hematology

description: Additional file 2: Table S1. Risk factors associated with blood transfusion after TLH
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab
Creators: name: Foss, Francine
name: Kim, Youn H.
name: Scarisbrick, Julia
name: Akilov, Oleg
name: Ristuccia, Robert
name: Dwyer, Karen
name: Wu, Wende
name: Bagot, Martine
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Medicine
subject: Genetics
subject: FOS: Biological sciences
subject: Environmental Sciences not elsewhere classified
subject: Ecology
subject: Immunology
subject: FOS: Clinical medicine
subject: Biological Sciences not elsewhere classified
subject: Cancer
subject: Science Policy
subject: Infectious Diseases
subject: FOS: Health sciences
subject: Plant Biology

description: Mogamulizumab demonstrated improved outcomes vs. vorinostat across a range of disease and patient characteristics in patients with mycosis fungoides or Sézary syndrome in the MAVORIC trial. This post-hoc analysis further examined MAVORIC data to assess factors associated with long-term response (ORR >12 months), time to next treatment (TTNT), and impact of concomitant steroid use, lymphopenia, and mogamulizumab-associated rash (MAR) on patient response. A higher proportion of patients achieved ORR lasting ≥4, 6, 8, or 12 months in the mogamulizumab vs. vorinostat arm. Long-term response was also observed in mogamulizumab-treated patients with more advanced disease (stage IVA1 [17/20], B2 blood involvement [18/20], and SS [14/20]). PFS was significantly longer (9.4 vs. 3.1 months; p < 0.0001) in mogamulizumab vs. vorinostat-treated patients taking concomitant steroids. Mogamulizumab-treated patients experienced longer TTNT vs. vorinostat. Lymphopenia and MAR were associated with response to mogamulizumab. MAVORIC demonstrated greater efficacy with mogamulizumab vs. vorinostat in relapsed/refractory patients with CTCL, including those with more advanced disease. Concomitant steroid use improved ORR and PFS but did not impact vorinostat outcomes. Overall responses occurred more frequently in mogamulizumab-treated patients that developed lymphopenia than those that did not. A higher percentage of patients with MAR had an overall response than those without MAR.
title: Getting Ready for VLBI Observations to the Moon
Creators: name: Panzenböck, Olivia Franziska
Publisher: name: TU Wien
Year: 2024
Subjects: subject: VLBI
subject: Mond
subject: VLBI
subject: Moon

description: Geodetic Very Long Baseline Interferometry (VLBI) is based on the observation of extra galactic radio sources, primarily quasars. In recent years, the concept of equipping artificial and natural celestial bodies, such as satellites and the Moon, with VLBI transmitters has emerged. This concept opens up new perspectives in the fields of geodesy, astronomy and spacecraft navigation. This thesis deals with the required models for the analysis, described by the precise positioning of a VLBI transmitter at the location of the Apollo 15 reflector on the Moon. The determined position is evaluated by analysing Lunar Laser Ranging (LLR) measurements. LLR measures the flight time of laser light pulses to travel from the LLR station to the LLR reflector on the lunar surface and back. Due to the considerable distance between the objects involved, the laser pulses are affected by several delays. These must be considered in the LLR analysis. In particular, this thesis focuses on the two dominant propagation delays, namely the atmospheric delay and the Shapiro time delay. The atmosphere causes a light propagation delay of 2 to 9 m. The Shapiro time delay can be subdivided into two components. The Sun is responsible for delays in the range of 6 to 8 m, while the Earth causes delays of a few centimetres. After modelling these delays, the residuals from 2002 to 2021 (no measurements available for 2006, 2007 and 2008) lie between -1 and +1 m.The second part of this thesis presents a visibility analysis of the VLBI transmitter on the lunar surface. For this purpose, modifications are made to the VLBI scheduling software VieSched++. The visibility is evaluated based on the elevation and the number of stations from which the VLBI transmitter is simultaneously visible. It was found that the number of hours per day during which the VLBI transmitter is visible varies considerably depending on the location of the VLBI station. Furthermore, the VLBI transmitter's visibility duration depends on the Moon's position. Therefore, to conduct successful VLBI observations to the Moon, it is essential to create an appropriate observation plan involving a globally distributed network of VLBI stations.
Additional file 3 of Risk factors for perioperative blood transfusion in patients undergoing total laparoscopic hysterectomy
Creators: name: Cao, Xianghua
name: Liu, Xueliang
name: Zhang, Xingxing
name: Zhang, Kefang
name: Chen, Chuan
name: Yang, Qinfeng
name: Wang, Jian
name: Li, Xueping
name: Wei, Ling
Publisher: name: figshare
Year: 2024
Subjects: Medicine
Pharmacology
Biotechnology
Hematology

description: Additional file 3: Table S2. Relationship between blood transfusion and preoperative comorbidities
Supplemental Material, sj-docx-1-jic-10.1177_0885066621989244 - Patients With Idiopathic Pulmonary Fibrosis Admitted to the ICU With Acute Respiratory Failure—A Reevaluation of the Risk Factors and Outcomes
Creators: name: Schrader, Matthew
name: Matheni Sathananthan
name: Niranjan Jeganathan
Publisher: name: SAGE Journals
Year: 2021
Subjects: subject: 110305 Emergency Medicine
subject: FOS: Clinical medicine
subject: 111702 Aged Health Care
subject: FOS: Health sciences
subject: 110203 Respiratory Diseases

description: Supplemental Material, sj-docx-1-jic-10.1177_0885066621989244 for Patients With Idiopathic Pulmonary Fibrosis Admitted to the ICU With Acute Respiratory Failure—A Reevaluation of the Risk Factors and Outcomes by Matthew Schrader, Matheni Sathananthan and Niranjan Jeganathan in Journal of Intensive Care Medicine
Personalized prediction of psoriasis relapse post-biologic discontinuation: a machine learning-driven population cohort study
Creators: name: Huang, Shan
name: Bai, Yanping
name: Qi, Ruozhou
name: Yu, Hongda
name: Duan, Xingwu
Publisher: name: Taylor & Francis
Year: 2025
Subjects: Medicine
Pharmacology
Biological Sciences not elsewhere classified
Science Policy

description: Identifying the risk of psoriasis relapse after discontinuing biologics can help optimize treatment strategies, potentially reducing relapse rates and alleviating the burden of disease management. To develop and validate a personalized prediction model for psoriasis relapse following the discontinuation of biologics. This study enrolled patients who achieved remission following biologic therapy. Relapse predictors were identified using the Boruta algorithm combined with multivariate Cox regression. A nomogram and an online calculator were created to aid in the visualization and computation of outcomes. The model’s performance was thoroughly assessed using Receiver Operating Characteristic (ROC) curves, Area Under the Curve (AUC), C-statistics, calibration plots, and Decision Curve Analysis (DCA). The study included 597 patients, with 534 in the derivation cohort and 63 in the validation cohort. Anxiety, disease duration, prior biologic treatments, treatment duration, time to achieve PASI 75, and maximum PASI response were identified as influential factors for relapse and were incorporated into the model. Both internal and external evaluations indicate that the model exhibits good predictive accuracy. A multivariate model leveraging standard clinical data can relatively accurately predict the risk of psoriasis relapse post-biologic discontinuation, guiding personalized treatment strategies.
E03494: Gregory of Tours, in his Miracles of Martin (3.10), recounts how his mother visited him in Tours and was cured of a recurrent pain in one leg after prayers to *Martin (ascetic and bishop of Tours, ob. 397, S00050); AD 573. Written in Latin in Tours (north-west Gaul), 582/588.
Creators: name: Kwojtalik
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: Gregory of Tours, Miracles of Martin (Libri de virtutibus sancti Martini episcopi) 3.10

Summary:

Gregory's own mother long suffered from a recurrent pain in one leg. After Gregory's consecration, she came to Tours, and, while there for two or three months, she frequently prayed to Martin for help. The pain that had tormented her for thirty-four years left her.

Text: Krusch 1969, 185. Summary: Katarzyna Wojtalik.
Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis
Creators: name: Blauvelt, Andrew
name: Kircik, Leon
name: Schlesinger, Todd
name: Pierce, Evangeline
name: Burge, Russel
name: Behling, Michael
name: Atwater, Amber Reck
name: ElMaraghy, Hany
name: Armstrong, April
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Microbiology
subject: FOS: Biological sciences
subject: Genetics
subject: Physiology
subject: Pharmacology
subject: Immunology
subject: FOS: Clinical medicine
subject: Developmental Biology
subject: Cancer
subject: Science Policy
subject: Mental Health

description: Lebrikizumab monotherapy significantly improved signs and symptoms in patients with moderate-to-severe atopic dermatitis (AD) in phase 3 Advocate1 and ADvocate2 studies. To evaluate improvements in patient-reported symptoms and quality-of-life (QoL) measures by Eczema Area and Severity Index (EASI) response categories using pooled Advocate1 and ADvocate2 data (post hoc analysis). In the 52-week (W) (16-W induction + 36-W maintenance) double-blind, placebo-controlled ADvocate1 and ADvocate2 studies, patients were randomized (2:1) to receive subcutaneous lebrikizumab 250 mg or placebo every 2 weeks. Investigator Global Assessment (IGA) 0/1 and improvements in QoL outcomes were assessed at W16 among lebrikizumab-treated patients. At W16, 564 patients were categorized by EASI response (EASI <50: 32.8%; EASI ≥50–<75: 13.8%; EASI ≥75–<90: 20.2%; EASI ≥90: 33.2%). Patients with higher EASI responses showed higher IGA 0/1 response rates (EASI ≥75–<90: 37.7% and EASI ≥90: 86.1%). Pruritus NRS (least squares mean range: −1.5 to −4.4), sleep-loss score (−0.6 to −1.6), and Dermatology Life Quality Index (−3.3 to −10.6) improved across EASI response categories (p < 0.001). Anxiety and depression scores improved for most EASI response categories (p < 0.01). Lebrikizumab-treated patients with moderate-to-severe AD showed improved symptoms and QoL across EASI response categories at W16, with greater improvements observed in patients with higher EASI responses.
Additional file 4 of Risk factors for perioperative blood transfusion in patients undergoing total laparoscopic hysterectomy
Creators: name: Cao, Xianghua
name: Liu, Xueliang
name: Zhang, Xingxing
name: Zhang, Kefang
name: Chen, Chuan
name: Yang, Qinfeng
name: Wang, Jian
name: Li, Xueping
name: Wei, Ling
Publisher: name: figshare
Year: 2024
Subjects: Medicine
Pharmacology
Biotechnology
Hematology

description: Additional file 4: Table S3. Relationship between blood transfusion and postoperative complications
Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
Creators: name: Law, Ernest H.
name: Hanson, Kent A.
name: Harries, Matthew
name: Korver, Dane
name: Sherif, Bintu
name: Chirila, Costel
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Space Science
subject: Medicine
subject: Physiology
subject: FOS: Biological sciences
subject: Pharmacology
subject: Biotechnology
subject: Chemical Sciences not elsewhere classified
subject: Immunology
subject: FOS: Clinical medicine
subject: Biological Sciences not elsewhere classified
subject: Developmental Biology
subject: Science Policy
subject: Mental Health

description: Purpose: Alopecia areata (AA), an autoimmune disorder characterized by non-scarring hair loss, is detrimental to the psychological health and quality of life of people living with AA. Clinically meaningful hair regrowth is possible, but the relationship with downstream patient-reported outcomes (PROs) is complex. Materials and methods: This post hoc analysis of ALLEGRO-2b/3 (NCT03732807) longitudinal data from Weeks 24–48 compared improvements in PROs between patients who achieved (responders) or did not achieve (non-responders) clinically meaningful scalp hair regrowth. Responders were defined by a Week 24 Severity of Alopecia Tool (SALT) score ≤20 (SALT20) or ≤10 (SALT10). Across 6 PROs assessing multiple AA-related health domains, response proportions and mean changes from baseline were estimated for Weeks 24–48. Results: Among 650 included participants, 114 (17.5%) were SALT20 responders, of which 76 (11.7%) were also SALT10 responders. Generally, more responders than non-responders reported improvements in AA and related symptoms or limitations and satisfaction with hair regrowth. Responders additionally reported greater improvement from baseline than non-responders for measures of AA-related emotional symptoms, mental health, and work or activity limitations. Conclusions: These results support a positive relationship between scalp hair regrowth and downstream PROs—including satisfaction and psychosocial burden—demonstrating an association between clinically meaningful hair regrowth and patient-reported treatment benefits.
sj-pdf-5-opp-10.1177_1078155221989404 - Supplemental material for PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients
Creators: name: Jahangiri, Rosa
name: Mosaffa, Fatemeh
name: Amirnader Emami Razavi
name: Teimoori-Toolabi, Ladan
name: Jamialahmadi, Khadijeh
Publisher: name: SAGE Journals
Year: 2021
Subjects: subject: 111299 Oncology and Carcinogenesis not elsewhere classified
subject: FOS: Clinical medicine
subject: 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified

description: Supplemental material, sj-pdf-5-opp-10.1177_1078155221989404 for PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients by Rosa Jahangiri, Fatemeh Mosaffa, Amirnader Emami Razavi, Ladan Teimoori-Toolabi and Khadijeh Jamialahmadi in Journal of Oncology Pharmacy Practice
sj-pdf-6-opp-10.1177_1078155221989404 - Supplemental material for PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients
Creators: name: Jahangiri, Rosa
name: Mosaffa, Fatemeh
name: Amirnader Emami Razavi
name: Teimoori-Toolabi, Ladan
name: Jamialahmadi, Khadijeh
Publisher: name: SAGE Journals
Year: 2021
Subjects: subject: 111299 Oncology and Carcinogenesis not elsewhere classified
subject: FOS: Clinical medicine
subject: 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified

description: Supplemental material, sj-pdf-6-opp-10.1177_1078155221989404 for PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients by Rosa Jahangiri, Fatemeh Mosaffa, Amirnader Emami Razavi, Ladan Teimoori-Toolabi and Khadijeh Jamialahmadi in Journal of Oncology Pharmacy Practice
Reshaping treatment paradigm in actinic keratosis by using a modified Delphi questionnaire
Creators: name: Dirschka, Thomas
name: Ardigò, Marco
name: Fargnoli, Maria Concetta
name: Ferrándiz-Pulido, Carla
name: Gilaberte, Yolanda
name: Hadshiew, Ina
name: Peris, Ketty
name: Szeimies, Rolf-Markus
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Medicine
subject: Cell Biology
subject: Pharmacology
subject: Biotechnology
subject: Science Policy
subject: Infectious Diseases
subject: FOS: Health sciences

description: Actinic keratosis (AK) is the main precursor of invasive cutaneous squamous cell carcinoma (cSCC). Since it is impossible to predict which lesions will progress to cSCC, early treatment of AK is crucial. Although AK treatments are effective, some are associated with local skin reactions that may impact treatment compliance and effectiveness. The aim of this modified Delphi study was to review the efficacy and safety of the different AK treatments, gain an understanding of the dermatologists’ perspectives on their use, and provide guidelines for clinical practice. This document corresponds to a modified Delphi consensus survey, based on a literature review and a single round of questionnaire. The Delphi questionnaire was completed by 73 dermatologists from Germany, Italy, and Spain. Agreement was achieved for 78% of statements, while 11% showed discrepancies or were rejected. Key findings emphasize the importance of patient-centered approaches and treatment attributes beyond efficacy (e.g. tolerability or adherence). Understanding the mechanisms of action of treatments is vital for managing patients’ and clinicians’ expectations and optimizing outcomes. Alternative strategies for evaluating efficacy, including the Actinic Keratosis Area and Severity Index (AKASI) score and lesion reduction from baseline, were also highlighted.
sj-pdf-1-isp-10.1177_0020764021991889 – Supplemental material for Importance of mental health awareness among school teachers in bridging mental health treatment gap in India
Creators: name: Fathima MA
name: Milu Maria Anto
Publisher: name: SAGE Journals
Year: 2021
Subjects: subject: 170199 Psychology not elsewhere classified
subject: FOS: Psychology
subject: 110319 Psychiatry (incl. Psychotherapy)
subject: FOS: Clinical medicine

description: Supplemental material, sj-pdf-1-isp-10.1177_0020764021991889 for Importance of mental health awareness among school teachers in bridging mental health treatment gap in India by Fathima MA and Milu Maria Anto in International Journal of Social Psychiatry
Hailey-Hailey disease successfully treated with naloxone: 2 case reports and Review of the literature on efficacy of opioid receptor antagonist in Hailey-Hailey disease patients
Creators: name: Zheng, Junyou
name: Duan, Zhimin
name: Xu, Beilei
name: Song, Hao
name: Wu, Jianbing
name: Fang, Fang
name: Sheng, Nan
name: Li, Chengrang
Publisher: name: Taylor & Francis
Year: 2025
Subjects: subject: Medicine
subject: Neuroscience
subject: Pharmacology
subject: Biotechnology
subject: Chemical Sciences not elsewhere classified
subject: Immunology
subject: FOS: Clinical medicine
subject: Cancer
subject: Hematology
subject: Infectious Diseases
subject: FOS: Health sciences

description: Hailey–Hailey disease (HHD), a genetic blistering disease, is caused by a mutation in a calcium transporter protein in the Golgi apparatus encoded by the ATP2C1 gene. Clinically, HHD is characterized by flaccid vesicles, blisters, erosions, fissures, and maceration mainly in intertriginous regions. Some patients remain refractory to conventional treatments. Previously, a series of reports have confirmed naltrexone as an effective option for those patients. However, in China, naltrexone is unavailable in some hospitals and unaffordable for some patients. To confirm naloxone as a treatment option for HHD, and assess the efficacy rate and safety of naltrexone for patients with HHD. Two patients with biopsy-proven HHD received naloxone (2 mg/d, via intravenous infusion). We followed up with the two patients, assessing the change of skin lesions and obtaining photographs. We searched the PubMed databases using the keywords ‘Hailey-Hailey disease’ or ‘benign familial pemphigus’, and ‘naltrexone’ or ‘naloxone’, and reviewed English publications of reports and analyzed the efficacy and safety of naltrexone. Two patients prescribed naloxone showed completely remission in two weeks without any adverse reactions. The total remission rate of naltrexone for HHD is approximately 80%, without severe adverse effects. Naltrexone is effective and safe in the treatment of HHD. Naloxone, an analog of naltrexone, can also effectively and safely treat HHD, potentially offering a new therapeutic option for patients with refractory HHD.
E03496: Greek inscription on a balance scale, possibly invoking the God of *George (soldier and martyr, S00259). Found at Dor (Tanturah) bay, to the north of Caesarea Maritima (Roman province of Palaestina I). Probably late antique.
Creators: name: Pnowakowski
Publisher: name: University of Oxford
Year: 2017
Subjects: History

description: The balance bears three inscriptions, punched on the short section of its lever:

Inscription C was transcribed by de Presle as: ΙCΧC Ο ΘΕ Γ Ε ΨΡ and expanded:

Ἰ(ησοῦ)ς Χ(ριστὸ)ς κ(αὶ) ὁ θε(ὸς) γ(εννηθεὶς), ἐ(λεήσον) Ψ(- - -) Ρ(- - -)

'Jesus Christ and begotten God, have mercy on Psates, of Rhion (or: Psates, son of Rhion)!'

Text: CIIP 2, no. 2143. Translation: W. Ameling, lightly modified.

However, Jean Gascou in Bulletin épigraphique (2013), 463 suggests a different reading of the inscription, based on the drawing published in CIIP 2:

(christogram) ΙCΧCΚΟΘΕΓΕΙΩΡ/ which can be expanded for example as (christogram) Ἰ(ησοῦ)ς Χ(ριστὸ)ς, Κ(ύρι)ε, Θ(ε)ὲ Γειωρ(γίου)/'(christogram) Jesus Christ, Lord, God of George!'

Gatier points out that the name George/Georgios is spelt in the same way (Γειώργιος) in Inscription A from the same balance: Ἰ(ησοῦ)ς Χ(ριστὸ)ς βοήθισον | Γειωργίου ΩΙCΟΙΟΝΟC/'Jesus Christ, give help to Georgios (Geiorgios), son of ...'

Inscription B says the balance was the property of Sotirichos and Artemon.